Human Telomerase Reverse Transcriptase (hTERT) expression in patients with Chronic Myelogenous Leukemia at defferent phases of the disease
Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. Telomerase- essential enzyme that adds telomeric repeats into the telomeres- maintains integrity of chromo...
Main Authors: | A Amini, SH Ghaffari, Y Mortazavi, N Eynolahi, K Alimoghadam, Sh Rostami, Y Gahani, A Ghavamzadeh |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2008-09-01
|
Series: | پیاورد سلامت |
Subjects: | |
Online Access: | http://payavard.tums.ac.ir/article-1-152-en.html |
Similar Items
-
Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Chronic Myelogenous Leukemia at Different Phases of the Disease
by: K Alimoghadam, et al.
Published: (2008-08-01) -
Mapping of the Gene for the Human Telomerase Reverse Transcriptase, hTERT, to Chromosome 5p15.33 by Fluorescence in Situ Hybridization
by: Lisa A. Bryce, et al.
Published: (2000-05-01) -
Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes
by: Anna A. Plyasova, et al.
Published: (2021-05-01) -
The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
by: Lorel M. Colgin, et al.
Published: (2000-09-01) -
Immunohistochemical Detection of Telomerase (hTERT) Protein in Human Cancer Tissues and a Subset of Cells in Normal Tissues
by: Eiso Hiyama, et al.
Published: (2001-01-01)